entertainment -WSS

entertainment

author：Wikipedia 2025-09-03 07:43:27 - browse：9

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： Peter Hotez and the public health issue of online harassment
Next article： New oral drug delivery patch is modeled after octopus tentacles

focus

explore

WSS

Lawsuit highlights wrinkle for disputes over surprise medical bills

7 people shot in DC, police say

European officials brace for rough respiratory virus season

Connecting traumatic brain injury and domestic violence

6 solutions to address cancer drug shortages and others

Stop Congress from blocking public access to science

Wikipedia

entertainment

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Make 'food is medicine' a key part of White House nutrition meeting

Heart attack and stroke risk calculators need revising

Health insurers' Q3 question: how much care are people getting?

Heart attack and stroke risk calculators need revising

What will Novo Nordisk's VC do with its influx of cash?

Medicare details structure of new drug price negotiation program

Nobel honors Karikó and Weissman's enduring partnership

How to save PrEP access — and even expand it

Option Care buys Amedisys in $3.6 billion home care deal

focus

Some top drug companies are starting to take action on climate

Some top drug companies are starting to take action on climate

European officials brace for rough respiratory virus season

RSV injection headlines need to be accurate for good uptake

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

New case study details death in closely watched Alzhiemer's trial

focus

explore

explore

explore